Ekaterina Kalashnikova

机构：Natera (United States) · ORCID：0000-0003-1078-0656

发表论文 104 篇 · 总被引 1356 次 · h-index 17

代表论文

Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumors (2025 · Nature Communications · 被引 16)
Circulating tumor (ct)DNA monitoring of ER+/HER2- high-risk breast cancer during adjuvant endocrine therapy. (2025 · Journal of Clinical Oncology · 被引 12)
Using Circulating Tumor DNA–Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer (2025 · JCO Precision Oncology · 被引 1)
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study (2025 · Annals of Surgical Oncology · 被引 1)
Supplementary Figure S5 from Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies (2026)
Supplementary Figure S4 from Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies (2026)